Search
for
Sort by
Research 871–900 of 1000+
- Venous thromboembolism and women's health
- Palladium nanoparticles on a pyridinium supported ionic liquid phase: a recyclable and low-leaching palladium catalyst for aminocarbonylation reactions
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Unlocking Dithranol’s Potential: Advanced Drug Delivery Systems for Improved Pharmacokinetics
- Decline of life’s energy theory of ageing 1. Revitalisation of energy metabolism and ageing mitochondria
- Milagros enterprise Group S.A.S.: high-quality products in hair health international business plan
- Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
- LAWSONIA INERMIS LINN’S POTENTIAL FOR PROMOTING WOUND HEALING: A REVIEW
- A Meta-Analysis on the Relationship Between Hair Dye and the Incidence of Non-Hodgkin’s Lymphoma
- The Dynamics of the Skin’s Immune System
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- Fat Transfer for the Management of Soft Tissue Trauma: The Do's and the Don'ts
- Recurrent Central Serous Retinopathy with Permanent Visual Loss in a U.S. Naval Fighter Pilot
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia
- Comparison of three strip harvesting technqiues (Haber's, Pathomvanich's and Ahmad's techniques)
- Areata progressing to totalis: A 24-month journey of hair regrowth at Dr. Batra’s
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Hormonal Control of Cardiac Action Potential Phase 1 Currents in the Brugada Syndrome
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Successful Homeopathic Management of Androgenetic Alopecia at Dr Batra’s
- Impact of ustekinumab on quality of life and sexual difficulties associated with psoriasis: Results from phase III clinical trials
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Therapeutic Potential of Nerve Growth Factor-Modified Hair Follicle Stem Cells Transplantation in a Rat Model of Alzheimer’s Disease
- Sustained clinical and psychosocial reversal of advanced male androgenetic alopecia through individualized classical homeopathy at Dr Batra’s homeopathy clinic: A longitudinal case report
- A Comparative Study to Evaluate Efficacy of Prachanna Karma Followed by Chirabilva Lepa and Gunja Lepa in the Management of Indralupta w.s.r to Alopecia Areata
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer